X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (26) 26
human necessities (26) 26
hygiene (26) 26
medical or veterinary science (26) 26
metallurgy (26) 26
preparations for medical, dental, or toilet purposes (26) 26
specific therapeutic activity of chemical compounds ormedicinal preparations (26) 26
heterocyclic compounds (19) 19
organic chemistry (19) 19
humans (16) 16
adult (14) 14
index medicus (14) 14
male (13) 13
middle aged (13) 13
female (12) 12
aged (11) 11
treatment outcome (8) 8
beer (7) 7
biochemistry (7) 7
compositions or test papers therefor (7) 7
condition-responsive control in microbiological orenzymological processes (7) 7
enzymology (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
measuring (7) 7
measuring or testing processes involving enzymes, nucleicacids or microorganisms (7) 7
microbiology (7) 7
mutation or genetic engineering (7) 7
oncology (7) 7
physics (7) 7
processes of preparing such compositions (7) 7
spirits (7) 7
testing (7) 7
vinegar (7) 7
wine (7) 7
clinical trials (6) 6
drug administration schedule (6) 6
care and treatment (5) 5
chemotherapy (5) 5
urology & nephrology (5) 5
abridged index medicus (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cisplatin - administration & dosage (4) 4
double-blind method (4) 4
follow-up studies (4) 4
microbial collagenase - administration & dosage (4) 4
penile induration - drug therapy (4) 4
studies (4) 4
therapy (4) 4
adenocarcinoma - drug therapy (3) 3
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
disease-free survival (3) 3
dose-response relationship, drug (3) 3
efficacy (3) 3
endothelial growth-factor (3) 3
fluorouracil - administration & dosage (3) 3
peyronie's disease (3) 3
pyrroles - administration & dosage (3) 3
su11248 (3) 3
tyrosine kinase inhibitor (3) 3
young adult (3) 3
adenocarcinoma (2) 2
adenocarcinoma - mortality (2) 2
adenocarcinoma - pathology (2) 2
anaplastic lymphoma (2) 2
breast cancer (2) 2
breast neoplasms - drug therapy (2) 2
cancer therapies (2) 2
carboplatin - administration & dosage (2) 2
carcinoma, non-small-cell lung - drug therapy (2) 2
cisplatin (2) 2
clostridium histolyticum (2) 2
clostridium histolyticum - enzymology (2) 2
cohort studies (2) 2
collagen (2) 2
collagenase (2) 2
collagenase clostridium histolyticum (2) 2
combination (2) 2
communication (2) 2
diagnosis (2) 2
distress (2) 2
fluorouracil - adverse effects (2) 2
guidelines (2) 2
indoles - administration & dosage (2) 2
indoles - adverse effects (2) 2
infusions, intravenous (2) 2
inhibitor drugs (2) 2
injections, intralesional (2) 2
kaplan-meier estimate (2) 2
lung cancer (2) 2
lung neoplasms - drug therapy (2) 2
maximum tolerated dose (2) 2
medical research (2) 2
medicine & public health (2) 2
medicine, experimental (2) 2
men (2) 2
metastasis (2) 2
microbial collagenase - pharmacokinetics (2) 2
microbial collagenase - therapeutic use (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | CISPLATIN | ADENOCARCINOMA | PHASE-III | KINASE | ANAPLASTIC LYMPHOMA | QLQ-C30 | PLUS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Lung cancer | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Chemotherapy | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 10, pp. 1341 - 1347
Journal Article
Investigational New Drugs, ISSN 0167-6997, 12/2011, Volume 29, Issue 6, pp. 1449 - 1458
Journal Article
Ecography, ISSN 0906-7590, 4/2010, Volume 33, Issue 2, pp. 315 - 320
Isolation by distance (IBD) has been a common measure of genetic structure among populations and is based on Euclidean distances among populations. Whereas IBD... 
Taxa | Landscapes | Ecological genetics | Mantels | P values | Evolutionary genetics | Genetic distance | Population genetics | Metapopulation ecology | Estimators | DISPERSAL | MOUNTAIN PASSES | BODY-SIZE | POPULATION-STRUCTURE | ECOLOGY | MODEL | BIODIVERSITY CONSERVATION | METABOLIC-RATE | TROPICS | FLOW | Analysis | Data processing
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2016, Volume 34, Issue 24, pp. 2858 - 2865
Journal Article
by De Placido, Sabino and Gallo, Ciro and De Laurentiis, Michelino and Bisagni, Giancarlo and Arpino, Grazia and Sarobba, Maria Giuseppa and Riccardi, Ferdinando and Russo, Antonio and Del Mastro, Lucia and Cogoni, Alessio Aligi and Cognetti, Francesco and Gori, Stefania and Foglietta, Jennifer and Frassoldati, Antonio and Amoroso, Domenico and Laudadio, Lucio and Moscetti, Luca and Montemurro, Filippo and Verusio, Claudio and Bernardo, Antonio and Lorusso, Vito and Gravina, Adriano and Moretti, Anna and Moretti, Gabriella and Lauria, Rossella and Lai, Antonella and Mocerino, Carmela and Rizzo, Sergio and Nuzzo, Antonio and Nuzzo, Francesco and Carlini, Paolo and Perrone, Francesco and Accurso, Antonello and Agostara, Biagio and Aieta, Michele and Alabiso, Oscar and Alicicco, Maria Grazia and Amadori, Dino and Amaducci, Laura and Amiconi, Gianna and Antuzzi, Giustino and Ardine, Mara and Ardizzoia, Antonio and Aversa, Caterina and Badalamenti, Giuseppe and Barni, Sandro and Basurto, Carlo and Berardi, Rossana and Bergamasco, Cinzia and Bidoli, Paolo and Bighin, Claudia and Biondi, Edoardo and Boni, Corrado and Borgonovo, Karen and Botta, Mario and Bravi, Stefano and Bruzzi, Paolo and Buono, Giuseppe and Butera, Alfredo and Caldara, Alessia and Candeloro, Giampiero and Cappelletti, Claudia and Cardalesi, Cinzia and Carfora, Elisabetta and Cariello, Anna and Carrozza, Francesco and Cartenì, Giacomo and Caruso, Michele and Casadei, Virginia and Casanova, Claudia and Castori, Luigi and Cavanna, Luigi and Cavazzini, Giovanna and Cazzaniga, Marina and Chilelli, Mario and Chiodini, Paolo and Chiorrini, Silvia and Ciardiello, Fortunato and Ciccarese, Mariangela and Cinieri, Saverio and Clerico, Mario and Coccaro, Mariarosa and Comande, Mario and Corbo, Claudia and Cortino, Giuseppina and Cusenza, Stefania and Daniele, Gennaro and D'arco, Alfonso Maria and D'auria, Giuliana and Dazzi, Claudio and De Angelis, Carmine and de Braud, Filippo and De Feo, Gianfranco and De Matteis, Andrea and De Tursi, Michele and Di Blasio, Anna and di Lucca, Giuseppe and Di Lullo, Liberato and Di Rella, Francesca and Di Renzo, Gianfranco and ... and GIM Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 474 - 485
Uncertainty exists about the optimal schedule of adjuvant treatment of breast cancer with aromatase inhibitors and, to our knowledge, no trial has directly... 
SYSTEM | THERAPY | EFFICACY | ONCOLOGY | FOLLOW-UP | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | Breast cancer | Product development | Tamoxifen | Analysis
Journal Article
Journal Article
Journal of Health Communication, ISSN 1081-0730, 07/2015, Volume 20, Issue 7, pp. 766 - 772
Crafting messages that capture consumer interest is a frequent challenge of health communicators. A better understanding of the techniques magazine editors use... 
UNITED-STATES | FOOD ADVERTISEMENTS | WOMENS MAGAZINES | MESSAGES | INFORMATION SCIENCE & LIBRARY SCIENCE | NUTRITION | COMMUNICATION | STRATEGIES | Mothers - psychology | Motivation | Health Communication - methods | Humans | Child, Preschool | Adult | Female | Infant | Mothers - statistics & numerical data | Child | Periodicals as Topic | Pediatric Obesity - prevention & control
Journal Article
Journal of Health Communication, ISSN 1081-0730, 07/2015, Volume 20, Issue 7, p. 766
  Crafting messages that capture consumer interest is a frequent challenge of health communicators. A better understanding of the techniques magazine editors... 
Reading | Motivation | Health | Mothers | Communication | Content analysis
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019
We analyzed data from 738 HER2-positive metastatic breast cancer (mbc) patients treated with pertuzumab-based regimens and/or T-DM1 at 45 Italian centers.... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2001, Volume 19, Issue 4, pp. 943 - 953
Journal Article